End Of A Marriage

Schering-Plough and Merck have been making moves to bring their two respective allergy drugs—Claritin and and Singulair—together to form one super-drug, but it according to a recent Wall Street Journal article, it doesn’t look like that is going to happen. On April 25, the company said late the FDA had rejected an application for a ...